Cargando…

Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs

BACKGROUND: Bleeding is a common, morbid, and costly complication of percutaneous coronary intervention. While bleeding avoidance strategies (BAS) are effective, they are used paradoxically less in patients at high risk of bleeding. Whether a patient‐centered approach to specifically increase the ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Amit P., Miller, Samantha, Rahn, Brandon, Caruso, Mary, Pierce, Andrew, Sorensen, Katrine, Kurz, Howard, Zajarias, Alan, Bach, Richard, Singh, Jasvindar, Lasala, John M., Kulkarni, Hemant, Crimmins‐Reda, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404202/
https://www.ncbi.nlm.nih.gov/pubmed/30376760
http://dx.doi.org/10.1161/JAHA.118.008551
_version_ 1783400824089608192
author Amin, Amit P.
Miller, Samantha
Rahn, Brandon
Caruso, Mary
Pierce, Andrew
Sorensen, Katrine
Kurz, Howard
Zajarias, Alan
Bach, Richard
Singh, Jasvindar
Lasala, John M.
Kulkarni, Hemant
Crimmins‐Reda, Patricia
author_facet Amin, Amit P.
Miller, Samantha
Rahn, Brandon
Caruso, Mary
Pierce, Andrew
Sorensen, Katrine
Kurz, Howard
Zajarias, Alan
Bach, Richard
Singh, Jasvindar
Lasala, John M.
Kulkarni, Hemant
Crimmins‐Reda, Patricia
author_sort Amin, Amit P.
collection PubMed
description BACKGROUND: Bleeding is a common, morbid, and costly complication of percutaneous coronary intervention. While bleeding avoidance strategies (BAS) are effective, they are used paradoxically less in patients at high risk of bleeding. Whether a patient‐centered approach to specifically increase the risk‐concordant use of BAS and, thus, reverse the risk‐treatment paradox is associated with reduced bleeding and costs is unknown. METHODS AND RESULTS: We implemented an intervention to reverse the bleeding risk‐treatment paradox at Barnes‐Jewish Hospital, St. Louis, MO, and examined: (1) the temporal trends in BAS use and (2) the association of risk‐concordant BAS use with bleeding and hospital costs of percutaneous coronary intervention. Among 3519 percutaneous coronary interventions, there was a significantly increasing trend (P=0.002) in risk‐concordant use of BAS. The bleeding incidence was 2% in the risk‐concordant group versus 9% in the risk‐discordant group (absolute risk difference, 7%; number needed to treat, 14). Risk‐concordant BAS use was associated with a 67% (95% confidence interval, 52–78%; P<0.001) reduction in the risk of bleeding and a $4738 (95% confidence interval, 3353–6122; P<0.001) reduction in per‐patient percutaneous coronary intervention hospitalization costs (21.6% cost‐savings). CONCLUSIONS: In this study, patient‐centered care directly aimed to make treatment‐related decisions based on predicted risk of bleeding, led to more risk‐concordant use of BAS and reversal of the risk‐treatment paradox. This, in turn, was associated with a reduction in bleeding and hospitalization costs. Larger multicentered studies are needed to corroborate these results. As clinical medicine moves toward personalization, both patients and hospitals can benefit from a simple practice change that encourages objectivity and mitigates variability in care.
format Online
Article
Text
id pubmed-6404202
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64042022019-03-18 Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs Amin, Amit P. Miller, Samantha Rahn, Brandon Caruso, Mary Pierce, Andrew Sorensen, Katrine Kurz, Howard Zajarias, Alan Bach, Richard Singh, Jasvindar Lasala, John M. Kulkarni, Hemant Crimmins‐Reda, Patricia J Am Heart Assoc Original Research BACKGROUND: Bleeding is a common, morbid, and costly complication of percutaneous coronary intervention. While bleeding avoidance strategies (BAS) are effective, they are used paradoxically less in patients at high risk of bleeding. Whether a patient‐centered approach to specifically increase the risk‐concordant use of BAS and, thus, reverse the risk‐treatment paradox is associated with reduced bleeding and costs is unknown. METHODS AND RESULTS: We implemented an intervention to reverse the bleeding risk‐treatment paradox at Barnes‐Jewish Hospital, St. Louis, MO, and examined: (1) the temporal trends in BAS use and (2) the association of risk‐concordant BAS use with bleeding and hospital costs of percutaneous coronary intervention. Among 3519 percutaneous coronary interventions, there was a significantly increasing trend (P=0.002) in risk‐concordant use of BAS. The bleeding incidence was 2% in the risk‐concordant group versus 9% in the risk‐discordant group (absolute risk difference, 7%; number needed to treat, 14). Risk‐concordant BAS use was associated with a 67% (95% confidence interval, 52–78%; P<0.001) reduction in the risk of bleeding and a $4738 (95% confidence interval, 3353–6122; P<0.001) reduction in per‐patient percutaneous coronary intervention hospitalization costs (21.6% cost‐savings). CONCLUSIONS: In this study, patient‐centered care directly aimed to make treatment‐related decisions based on predicted risk of bleeding, led to more risk‐concordant use of BAS and reversal of the risk‐treatment paradox. This, in turn, was associated with a reduction in bleeding and hospitalization costs. Larger multicentered studies are needed to corroborate these results. As clinical medicine moves toward personalization, both patients and hospitals can benefit from a simple practice change that encourages objectivity and mitigates variability in care. John Wiley and Sons Inc. 2018-10-31 /pmc/articles/PMC6404202/ /pubmed/30376760 http://dx.doi.org/10.1161/JAHA.118.008551 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Amin, Amit P.
Miller, Samantha
Rahn, Brandon
Caruso, Mary
Pierce, Andrew
Sorensen, Katrine
Kurz, Howard
Zajarias, Alan
Bach, Richard
Singh, Jasvindar
Lasala, John M.
Kulkarni, Hemant
Crimmins‐Reda, Patricia
Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
title Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
title_full Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
title_fullStr Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
title_full_unstemmed Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
title_short Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
title_sort reversing the “risk‐treatment paradox” of bleeding in patients undergoing percutaneous coronary intervention: risk‐concordant use of bleeding avoidance strategies is associated with reduced bleeding and lower costs
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404202/
https://www.ncbi.nlm.nih.gov/pubmed/30376760
http://dx.doi.org/10.1161/JAHA.118.008551
work_keys_str_mv AT aminamitp reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT millersamantha reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT rahnbrandon reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT carusomary reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT pierceandrew reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT sorensenkatrine reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT kurzhoward reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT zajariasalan reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT bachrichard reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT singhjasvindar reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT lasalajohnm reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT kulkarnihemant reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts
AT crimminsredapatricia reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts